Relationship between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation from Human Plasma

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S346-S349

  Spengler, Jessica R ^a   McElroy, Anita K ^a,b   Harmon, Jessica R ^a,b   Ströher, Ute ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Ebola; qRT PCR; virus isolation

Indexed keywords

BRINCIDOFOVIR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TKM 100802; VIRUS NUCLEOPROTEIN; ZMAPP; IMMUNOGLOBULIN G; NUCLEOPROTEIN;

ANTIBODY TITER; ARTICLE; CASE REPORT; CONVALESCENCE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; LONGITUDINAL STUDY; NONHUMAN; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS LOAD; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; GENETICS; IMMUNOLOGY; PROCEDURES; VERO CELL LINE; VIROLOGY;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; NUCLEOPROTEINS; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; VERO CELLS;

EID: 84942299591     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv187     Document Type: Article

References (17)

1. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196(suppl 2):S142-7.
2. Rodriguez LL, Roo De A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl):S170-6.
3. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41.
4. Towner JS, Khristova ML, Sealy TK, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497-516.
5. Grolla A, Jones SM, Fernando L, et al. The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis 2011; 5:e1183.
6. Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5: e1000536.
7. Amman BR, Jones MEB, Sealy TK, et al. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 2014; 51:113-24.
8. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007; 196:S205-12.
9. McElroy AK, Akondy RS, Davis CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015; 112:4719-24.
10. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014; 371: 2402-9.
11. Kraft CS, Hewlett A, Koepsell S, et al. The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin Microbiol Infect 2015; doi:10.1093/cid/civ334.
12. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in kikwit, democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(suppl 1):177-87.
13. Kreuels B,Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014; 371:2394-401.
14. Wong G, Audet J, Fernando L, et al. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine 2014; 32:5722-9.
15. Qiu X, Audet J, Wong G, et al. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 2013; 3:3365.
16. Dye JM, Herbert AS, Kuehne AI, et al. Postexposure antibody prophylaxis protects nonhuman primates from fi lovirus disease. Proc Natl Acad Sci U S A 2012; 109:1-6.
17. WHO Ebola Response Team. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371:1481-95.